Submission Deadline: 31 March 2024 (Status: Closed)
Special Issue Editor(s)
Prof. Majid Monajjemi
Email
|
Website
Department of Chemical Engineering, Central Tehran Branch, Islamic Azad University, Tehran, Iran
Interests:
nano biotechnology; drug design and drug delivery; quantum biology; biophysical chemistry; thermodynamic and thermochemistry; molecular dynamic simulation; docking methods; natural product technologies
Special Issue Information
Dear Colleagues,
Along with the genetic knowledge, a novel therapeutic strategy in the route of gene editing based on repeat/CRISPR-associated nuclease 9 which is known as the CRISPR/Cas9 method, was discovered as an immune-based sequence therapy method in various cancers. After follow-up research, this method is widely and was used as a gene editing tool for several cancer treatments. For instance, through the evaluation of novel research in Hepatocellular carcinoma (HCC is the most general of liver cancer), it is found that CRISPR/Cas9 would promote cancer research and provide a new tool for these types of genetic treatments in prospect. Since Hepatocellular carcinoma appears most often in people with chronic liver diseases, such as cirrhosis caused by hepatitis B or hepatitis C infection and Patients suffer from HCC since its high malignancy and limited treatment means, Crisper cas9 method is able to treat these types of disease properly. This Special Issue will focus on more recent studies dealing with cancer diseases' secondary metabolites and in vitro or in vivo medical treatment using any experimental research including crisper cas9 methods and theoretical simulation. To this purpose, original research articles, reviews, and short communications are welcome.
Prof. Majid Monajjemi
Guest Editor
Keywords
CRISPR/Cas9; hepatocellular carcinoma; gene editing; cancer therapy; drug design; drug delivery; nano biotechnology
Manuscript Submission Information
Manuscripts should be submitted via our online editorial system at https://www.biolifesas.org/journalx_brha/authorLogOn.action by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. Submitted manuscripts should be well formatted in good English.
